Patents by Inventor Srikanth Natarajan

Srikanth Natarajan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020156882
    Abstract: A method and system are described for identifying the source of an event in a computer network. In accordance with exemplary embodiments of the present invention, an identifier tag is associated with an event occurring within the computer network, wherein the identifier tag uniquely identifies at least one collection computer monitoring the event. At least one management computer receives information from the at least one collection computer that includes the identifier tag. The at least one management computer derives an identification of each collection computer from the identifier tag. The source of the event is identified to a user using the identification of each collection computer.
    Type: Application
    Filed: April 20, 2001
    Publication date: October 24, 2002
    Inventors: Srikanth Natarajan, Darren D. Smith
  • Publication number: 20020091857
    Abstract: A preferred system includes a processor, a discovery mechanism, and a connector evaluation mechanism. The discovery mechanism is configured to generate and store topology data specifying connectors and segments of a communication network. Additionally, the discovery mechanism is configured to determine a path between a start node and an end node based upon the topology data. For instance, such a path(s) may be based upon information corresponding to a type of path of interest and/or information corresponding to a type of connector of interest. The connector evaluation mechanism is configured to evaluate the connectors in the path.
    Type: Application
    Filed: October 25, 2001
    Publication date: July 11, 2002
    Inventors: Jeffrey R. Conrad, Srikanth Natarajan
  • Patent number: 6393385
    Abstract: A simulator for simulating a digital circuit, includes an input circuit for inputting a test patterns to describe the characteristics of the digital circuit and for inputting input signals to test the operation of digital circuit and output signals to describe the expected output of the digital circuit based on the input signals, an applying circuit to apply the input signal to test the operation of the digital circuit to the test patterns to describe the characteristics of the digital circuit to form a simulated output signal to indicate a response based on the test pattern, a comparator circuit to compare the simulated output signal with the output signal to describe the expected output of the digital circuit based on the input signals to determine a difference between the simulated output signal and the output signals, wherein the operation of the simulation is stopped if the difference is greater than a predetermined difference.
    Type: Grant
    Filed: May 28, 1996
    Date of Patent: May 21, 2002
    Assignee: Texas Instruments Incorporated
    Inventors: Vivek G. Pawar, Srikanth Natarajan, C. Srinivasan
  • Patent number: 5459139
    Abstract: The synthesis and the biological evaluation of a series of basic ethers of 2-benzyl-3-arylbenzofurans as antitumor agents is described. These compounds bind significantly to the antiestrogen-binding sites but only poorly to the estrogen receptor sites and are cytotoxic to tumor cells. Some of these compounds also significantly inhibited de novo cholesterol biosynthesis in an estrogen receptor negative lymphoma cell line rich in antiestrogen-binding sites.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: October 17, 1995
    Assignee: National University of Singapore
    Inventors: Keng-Yeow Sim, Oi-Lian Kon, Chin-Chin Teo, Siu-Choon Ng, Srikanth Natarajan
  • Patent number: 5354861
    Abstract: The synthesis and the biological evaluation of a series of basic ethers of 2-benzyl-3-arylbenzofurans as antitumor agents is described. These compounds bind significantly to the antiestrogen-binding sites but only poorly to the estrogen receptor sites and are cytotoxic to tumor cells. Some of these compounds also significantly inhibited de novo cholesterol biosynthesis in an estrogen receptor negative lymphoma cell line rich in antiestrogen-binding sites.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: October 11, 1994
    Assignee: National University of Singapore
    Inventors: Keng-Yeow Sim, Oi-Lian Kon, Chin-Chin Teo, Siu-Choon Ng, Srikanth Natarajan